Detalhe da pesquisa
1.
Basal Ganglia Atrophy as a Marker for Prodromal X-Linked Dystonia-Parkinsonism.
Ann Neurol
; 93(5): 999-1011, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36646669
2.
Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson's disease.
Mol Med
; 28(1): 28, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35246038
3.
Sweets for my sweet: modulation of the limbic system drives salience for sweet foods after deep brain stimulation in Parkinson's disease.
J Neurol Neurosurg Psychiatry
; 93(3): 324-331, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34911783
4.
Prodromal X-Linked Dystonia-Parkinsonism is Characterized by a Subclinical Motor Phenotype.
Mov Disord
; 37(7): 1474-1482, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35491955
5.
Imaging gradual neurodegeneration in a basal ganglia model disease.
Ann Neurol
; 86(4): 517-526, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31376168
6.
A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.
Ann Neurol
; 85(6): 812-822, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30973967
7.
Basal ganglia and cerebellar pathology in X-linked dystonia-parkinsonism.
Brain
; 141(10): 2995-3008, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30169601
8.
Letter to the Editor about the Ongre et al. publication: 'Progression of fatigue in Parkinson's disease-a 9-year follow-up' (Eur J Neurol 2020. doi: 10.1111/ene.14520).
Eur J Neurol
; 28(6): e35-e36, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33459455
9.
Depressive symptoms in Parkinson's disease are insufficiently but more often treated than in other chronic conditions.
NPJ Parkinsons Dis
; 9(1): 113, 2023 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452071
10.
Oculomotor abnormalities indicate early executive dysfunction in prodromal X-linked dystonia-parkinsonism (XDP).
J Neurol
; 270(9): 4262-4275, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191726
11.
Pronounced Orthostatic Hypotension in GBA-Related Parkinson's Disease.
J Parkinsons Dis
; 12(5): 1539-1544, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35491800
12.
Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson's Disease.
J Parkinsons Dis
; 12(4): 1191-1200, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35180131
13.
Increased Subcortical Sodium Levels in Patients with Progressive Supranuclear Palsy.
Biomedicines
; 10(7)2022 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35885033
14.
Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31P-MRSI.
Neurology
; 2022 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36195453
15.
Subthalamic nucleus conditioning reduces premotor-motor interaction in Parkinson's disease.
Parkinsonism Relat Disord
; 96: 6-12, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35093853
16.
Subthalamic Nucleus Stimulation Impairs Sequence Processing in Patients with Parkinson's Disease.
J Parkinsons Dis
; 11(4): 1869-1879, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34459415
17.
Clinical MR imaging in Parkinson's disease: How useful is the swallow tail sign?
Brain Behav
; 11(7): e02202, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34032020
18.
Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease.
Neurology
; 97(10): e1007-e1016, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34187859
19.
Identifying genetic modifiers of age-associated penetrance in X-linked dystonia-parkinsonism.
Nat Commun
; 12(1): 3216, 2021 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050153
20.
Permanent lesion to the corticospinal tract after therapy with capecitabine.
BMJ Case Rep
; 12(9)2019 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537598